{"id":"NCT01345019","sponsor":"Amgen","briefTitle":"Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma","officialTitle":"A Randomized, Double-Blind, Multicenter Study of Denosumab Compared With Zoledronic Acid in the Treatment of Bone Disease in Subjects With Newly Diagnosed Multiple Myeloma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-05-17","primaryCompletion":"2016-07-19","completion":"2019-03-29","firstPosted":"2011-04-29","resultsPosted":"2018-03-07","lastUpdate":"2022-11-08"},"enrollment":1718,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Cancer","Hematologic Malignancies","Multiple Myeloma","Oncology","Bone Metastases","Multiple Myeloma Bone Lesions"],"interventions":[{"type":"DRUG","name":"Denosumab","otherNames":["XGEVA速","AMG 162"]},{"type":"DRUG","name":"Zoledronic acid","otherNames":["Zometa速"]},{"type":"DRUG","name":"Placebo to Denosumab","otherNames":[]},{"type":"DRUG","name":"Placebo to zoledronic acid","otherNames":[]},{"type":"DRUG","name":"Denosumab (for the open-label treatment phase)","otherNames":["XGEVA速","AMG 162"]}],"arms":[{"label":"Zoledronic acid","type":"ACTIVE_COMPARATOR"},{"label":"Denosumab","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to determine if denosumab is non-inferior to zoledronic acid in the treatment of bone disease from multiple myeloma.","primaryOutcome":{"measure":"Time to First On-study Skeletal Related Event","timeFrame":"From randomization until the primary analysis data cut-off date of 19 July 2016 (per protocol); median time on study was 17.6 and 17.3 months in each treatment group respectively.","effectByArm":[{"arm":"Zoledronic Acid","deltaMin":730,"sd":null},{"arm":"Denosumab","deltaMin":695,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.010"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":9,"exclusionCount":19},"locations":{"siteCount":309,"countries":["United States","Australia","Austria","Bulgaria","Canada","Czechia","France","Germany","Greece","Hong Kong","Hungary","Ireland","Italy","Japan","Lithuania","Malaysia","New Zealand","Poland","Portugal","Russia","Singapore","Slovakia","South Korea","Spain","Switzerland","Taiwan","Turkey (T端rkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["29480139","29429912","32524500","33560384"],"seeAlso":["http://www.amgentrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":447,"n":852},"commonTop":["Diarrhoea","Nausea","Anaemia","Fatigue","Back pain"]}}